---
figid: PMC11908393__JIR-18-3555-g0008
figtitle: Tenascin-C induces microglial polarization through the TLR4/MyD88/NFKB pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11908393
filename: JIR-18-3555-g0008.jpg
figlink: /pmc/articles/PMC11908393/figure/F8/
number: F8
caption: Tenascin-C induces microglial polarization through the TLR4/MyD88/NF-κB pathway.
  After subarachnoid hemorrhage, the expression level of Tenascin-C increases. It
  induces the activation of microglia through the TLR4/MyD88/NF-κB signaling pathway,
  releases a large number of inflammatory factors TNF-α and IL-1β, promotes neuron
  damage, blood - brain barrier disruption, etc. Imatinib can effectively reduce Tenascin-C
  induced early brain injury
papertitle: Tenascin-C Facilitates Microglial Polarization via TLR4/MyD88/NF-κB Pathway
  Following Subarachnoid Hemorrhage
reftext: Zheng-Qing Hu, et al. J Inflamm Res. 2025;18(NA).
year: '2025'
doi: 10.2147/JIR.S511378
journal_title: Journal of Inflammation Research
journal_nlm_ta: J Inflamm Res
publisher_name: Dove Press
keywords: SAH | microglia | Tenascin-C | polarization
automl_pathway: 0.9364442
figid_alias: PMC11908393__F8
figtype: Figure
redirect_from: /figures/PMC11908393__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11908393__JIR-18-3555-g0008.html
  '@type': Dataset
  description: Tenascin-C induces microglial polarization through the TLR4/MyD88/NF-κB
    pathway. After subarachnoid hemorrhage, the expression level of Tenascin-C increases.
    It induces the activation of microglia through the TLR4/MyD88/NF-κB signaling
    pathway, releases a large number of inflammatory factors TNF-α and IL-1β, promotes
    neuron damage, blood - brain barrier disruption, etc. Imatinib can effectively
    reduce Tenascin-C induced early brain injury
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1A
  - IL1B
  - TNF
  - NFKB1
  - TNC
  - TNNC1
  - TLR4
  - MYD88
  - ACSM3
  - TNF-a
  - imatinib
  - SAH
---
